Additional Infectious Disease Controls

Specialty Infectious Disease Controls

eqas_immunoassay

 

CryptoTrol™

For use as an unassayed quality control with assays detecting capsular polysaccharide antigens of Cryptococcus neoformans.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTE

Cryptococcus neoformans Ag


Refer to the package insert for performance and stability claims


CryptoTrol™ LX

For use as an unassayed quality control in enzyme immunoassay and latex agglutination based test systems for qualitative and semi-quantitative detection of capsular polysaccharide antigens of Cryptococcus neoformans.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTE

Cryptococcus neoformans Ag


Refer to the package insert for performance and stability claims


VIROCLEAR® EBV

For use as an unassayed, non-reactive quality control with assays detecting IgG and IgM antibodies to the viral capsid antigen of Epstein-Barr Virus, IgG antibodies to early antigen and IgG antibodies to the viral polypeptide nuclear antigen of Epstein-Barr Virus.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTES

Epstein-Barr Virus (VCA) IgG

Epstein-Barr Virus (VCA) IgM

EBV EA IgG

EBNA IgG


Refer to the package insert for performance and stability claims


VIROTROL® EBV

For use as an unassayed quality control with assays detecting IgG and IgM antibodies to the viral capsid antigen of Epstein-Barr virus and IgG antibodies to Epstein-Barr virus nuclear antigen.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTES

Epstein-Barr Virus (VCA) IgG

Epstein-Barr Virus (VCA) IgM

EBNA IgG


Refer to the package insert for performance and stability claims


VIROTROL® WNV

An unassayed quality control for use with assays detecting Immunoglobulin G and Immunoglobulin M antibodies to West Nile Virus.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTES

West Nile Virus IgG

West Nile Virus IgM


Refer to the package insert for performance and stability claims


PneumoTrol™

For use as an unassayed quality control with assays detecting IgG and IgM antibodies to Mycoplasma pneumoniae and IgG antibodies to Chlamydia species.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTES

Mycoplasma pneumoniae IgG

Mycoplasma pneumoniae IgM

Chlamydia trachomatis IgG


Refer to the package insert for performance and stability claims


PyloriTrol™

For use as an unassayed quality controlwith assays detecting IgG antibodies toHelicobacter pylori.

  • Human serum based
  • 60 day open-vial stability at 2–8º C

ANALYTE

Helicobacter pylori IgG


Refer to the package insert for performance and stability claims


VIROTROL® Lyme

For use as an unassayed quality control with assays detecting Immunoglobulin G antibodies to Borrelia burgdorferi.

  • Human serum based
  • 60 day open-vial stability at 2–8º C
  • Convenient liquid formulation eliminates potential reconstitution variability

ANALYTE

Borrelia burgdorferi IgG


Refer to the package insert for performance and stability claims


VIROTROL® Chagas

An unassayed, reactive quality control for use with assays for the qualitative detection of antibodies to Trypanosoma cruzi (T. cruzi) in human serum or plasma. T. cruzi is characteristically associated with Chagas disease.

  • Human serum based
  • Liquid stable, ready to use
  • 2 year shelf life at 2–8°C
  • 60 day open-vial stability at 2–8º C

ANALYTE

Trypanosoma cruzi (T. cruzi)


Refer to the package insert for performance and stability claims

contact us For any questions related to this product please contact our
Technical Service Department at 1-800-854-6737
For Bio-Rad's Clinical Diagnostics corporate website, please visit www.bio-rad.com
 

Termék & Információ keresése

Události-akce

0
PLEASE LOG IN NOT REGISTERED?
Login ID
Password
  

.